- Home
- FENC vs SITC Comparison
FENC vs SITC Comparison
Compare FENC & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$10.11
HOLD
Current Price
$4.39
Company Overview
Basic Information| Metric | FENC | SITC |
|---|---|---|
| Founded | 1996 | 1965 |
| Country | United States | United States |
| Employees | N/A | 155 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 240.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENC | SITC |
|---|---|---|
| Price | $10.11 | $4.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $14.50 | $8.00 |
| AVG Volume (30 Days) | 193.6K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 123.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $1,015.00 | ★ $12.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $3.91 |
| 52 Week High | $11.31 | $12.39 |
Technical Indicators
Market Signals| Indicator | FENC | SITC |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 45.77 |
| Support Level | $10.04 | $4.16 |
| Resistance Level | $10.45 | $4.57 |
| Average True Range (ATR) | 0.56 | 0.13 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 20.07 | 53.66 |
Price Performance
Historical Comparison FENC
SITC
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.